Biopharmaceuticals
Delivering high-quality, low-cost biopharmaceuticals to more patients.
Yoshindo Holdings applies the knowledge and expertise it has cultivated through pharmaceutical research and manufacturing to the field of biopharmaceuticals, pursuing both quality and stable supply.
While biopharmaceuticals are expected to provide high therapeutic efficacy, their impact on medical costs remains a challenge. Based on our policy of contributing to the health of more patients through low-cost biopharmaceuticals, we are engaged in the development of biosimilars.
Expanding the Possibilities of Healthcare Through Biopharmaceuticals
Going beyond the limits of treatment and advancing healthcare
Biopharmaceuticals have greatly expanded the possibilities of healthcare by providing high therapeutic efficacy for diseases such as autoimmune diseases, cancer, and chronic diseases, where conventional small-molecule drugs have not always been sufficiently effective.
By improving treatment outcomes for many patients and helping raise the overall quality of healthcare, biopharmaceuticals have become an indispensable part of modern medicine.
Development Areas
Delivering High Clinical Value to Healthcare
The biosimilars we are developing target biopharmaceuticals with established clinical efficacy and safety, including human monoclonal antibody products.
By ensuring a stable supply of these pharmaceuticals with high therapeutic efficacy while maintaining the quality of healthcare, we aim to support the treatment of many patients and contribute to medical practice.
Development Structure
An Integrated System from R&D to Supply
In the biopharmaceutical business, Yoshindo Holdings has established an integrated system covering research and development, regulatory approval applications, manufacturing, and sales.
By bringing together the biosimilar development knowledge and technologies cultivated across the Group within Yoshindo Holdings, we are able to achieve rapid decision-making, improved development efficiency, and a stable product supply.
Furthermore, through collaboration with overseas partners, we are promoting the practical application of biopharmaceuticals that contribute to healthcare in Japan, while incorporating world-class quality and technology.
Business Introduction
